PEDROZA, L. G. V.; PEDROZA, Luís Gustavo Vedovelli.
Resumen:
Neonatal Screening Programs (NSP) purposes to detect various metabolic disorders that might occur in an early and severe way, but effective interventions are possible by introducing the treatment in its preclinical phase. All this effort to carry out a neonatal screening program is due to the fact that if left untreated, the disorder has serious consequences for the health of the affected. The data obtained in a previous research carried out by the analysis of the Alice de Almeida Hospital and Maternity records, located in the city of Sumé, state of Paraíba, included annotations referring to the triads, where the reference values of the tests were identified the individuals who had Some of the four pathologies that could be identified, Phenylketonuria (PKU), Hypothyroidism (TSH), Hemoglobinopathies (HB) and/or Cystic Fibrosis (CF). In the period from 2005 to 2015, 2921 newborn (NB) were registered. At this study were detected Twenty-two PKU cases, twenty-one cases of TSH, one case of sickle cell anemia and no cases of Cystic Fibrosis. The previous study resulted in data considered alarming since they showed that the occurrence of PKU is 90.9 times higher than the United Nations estimate and that the occurrence of TSH is 25.17 times higher than the number of cases at the national level. Therefore, the present study intended to further investigate the real situation of the patients through interviews for greater validation of the data. Initially, an examination was performed on a sample of 20 patients, however outstanding to the difficulty of locating the same, interviews with 10 of those affected and what was observed was that most of the interviewees received a different diagnosis or even are conscious of any diagnosed pathology, showing divergence in the content of the Hospital's records.
